Indeed, we observed a low effective-dose as well as a wide therapeutic window of coagulase fusion proteins, including tCoa-RGD [14] and tCoa-NGR (this study), in various xenograft tumor models, where large tumors with neovasculature were established. Here, RTN4R is linked to neoplasm.